Compromised Outcomes in Stage IV Non-Small-Cell Lung Cancer With Actionable Mutations Initially Treated Without Tyrosine Kinase Inhibitors: A Retrospective Analysis of Real-World Data
早期未接受酪氨酸激酶抑制剂治疗的IV期非小细胞肺癌伴可靶向突变患者预后不良：一项基于真实世界数据的回顾性分析
期刊:Jco Oncology Practice
影响因子:4.6
doi:10.1200/OP.22.00611
Scott, Jeffrey A; Lennerz, Jochen; Johnson, Melissa Lynne; Gordan, Lucio N; Dumanois, Robert H; Quagliata, Luca; Ritterhouse, Lauren L; Cappuzzo, Federico; Wang, Brandon; Xue, Mei; Vasudevan, Anupama; Varughese, Prateesh; Vaidya, Varun; Gart, Mike; Dorrow, Natalie; Gierman, Hinco J; Choksi, Rushir J
